Sedadex, which has the active ingredient dexmedetomidine, is indicated for sedation and analgesia and for premedication prior to general anaesthesia in dogs and cats. It comes in a 10 ml vial and has a 56-day broached shelf life.
Claire Morgan, Brand Manager from Dechra said: “Sedadex is a highly selective α2 adrenoceptor agonist that is licensed for intravenous or intramuscular use in dogs and intramuscular injection in cats.
“It is a welcome addition to Dechra’s anaesthesia and analgesia range and compliments our existing therapies that include Comfortan, Sedator and Atipam”
